The endoscope reprocessing device market is estimated to reach USD 2.68 billion in 2025. It is anticipated to grow at a CAGR of 7.3% during the assessment period and reach a value of USD 4.94 billion by 2035.
| Attributes | Description |
|---|---|
| Estimated Endoscope Reprocessing Device Market Size (2025E) | USD 2.68 billion |
| Projected Endoscope Reprocessing Device Market Value (2035F) | USD 4.94 billion |
| Value-based CAGR (2025 to 2035) | 7.3% |
The problem of the rising incidence of cardiovascular diseases has led to endoscopies being performed in a higher measure. As a result, devices associated with endoscopies, such as reprocessing devices are seeing greater adoption. Rising consciousness regarding Healthcare-Associated Infections (HAIs) is another factor prompting greater use of these devices.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Regulatory bodies around the world have introduced stringent measures for the reprocessing of medical devices. Endoscopes come within that purview, necessitating the increased use of reprocessing devices in healthcare facilities.
Non-compliance with these regulations has the ability to incur severe punishments, including penalties, loss of accreditation, and reputational damage, not to mention harm to patients. Hence, healthcare facilities are diligently adopting reprocessing devices.
The following table provides the various regulatory bodies that mandate the use of reprocessing devices.
| Regulatory Body | Recommendations |
|---|---|
| Centers for Disease Control and Prevention (CDC) | Use of high-level disinfection and sterilization for semi-critical devices like endoscopes |
| Association for the Advancement of Medical Instrumentation (AAMI) | Standards like AAMI ST91 for reprocessing endoscopes |
| Food and Drug Administration (FDA) | Manufacturers are required to provide data that reprocessing has been effective for endoscopes |
| European Union Medical Device Regulation (EU MDR) | Stringent rules regarding the use of endoscopes in Europe |
The following table highlights some of the recent innovations and their impact.
| Innovation | Impact |
|---|---|
| Modern automatic endoscope reprocessors (AERs) | Handling of multiple scopes simultaneously. |
| Hydrogen Peroxide Vapor or Ozone-Based Systems | Faster, safer, and eco-friendlier working. |
| Barcode Scanning and Digital Record-Keeping | Tracking of every step in the reprocessing cycle. |
| Eco-Friendly Disinfectants | Adding to more sustainability oriented healthcare settings. |
Advanced automatic endoscope reprocessors and sterilization systems are costly and require a high initial investment. Most healthcare facilities, especially in developing regions, cannot afford to spend such large amounts of money.
Regular maintenance of the reprocessing device is necessary for its efficacy and compliance with the standards. This increases cost in the form of service charges and maintenance contracts. Consumables used in the reprocessing activity, like high-level disinfectants, enzymatic detergents, sterile water, and filters, can also be cost-intensive.
Quite often, sophisticated devices for reprocessing require upgrading infrastructures such as dedicated spaces, water supply, and ventilation. Installation and operation are prohibitive for small hospitals and clinics.
Adequate training of the staff operating these devices and following the reprocessing protocols is needed. Training programs are expensive and take a long time to initiate, especially in institutions with rapid turnover rates among the personnel. Hence, the labor costs associated with the devices is also high.
Large Number of Endoscopies Performed in Hospitals Leading to Greater Use of Endoscopy Reprocessing Devices
| Attributes | Details |
|---|---|
| Top End Use | Hospitals |
| Market Share in 2025 | 55.6% |
Hospitals are the primary end users of endoscopy reprocessing devices. This segment is likely to account for 55.6% of the value share in 2025.
Most endoscopy procedures are performed in hospitals. Patients and their relatives have an implicit trust in hospitals and their staff. As a result, the number of endoscopies is increasing substantially in hospitals. This is leading to more recourse towards endoscopy reprocessing devices.
Safety and Efficiency of Automated Endoscope Reprocessors Preferred by End Users
| Attributes | Details |
|---|---|
| Top Product | Automated Endoscope Reprocessor |
| Market Share in 2025 | 45.3% |
Endoscopy reprocessing devices are majorly used in the form of automated endoscope reprocessors. These reprocessors is likely to account for 45.3% of the value share in 2025.
The automated endoscope reprocessor segment is the most significant in the market for endoscopy reprocessing devices, mainly attributed to its efficiency and safety. Automated cleaning and disinfection by AERs significantly reduce processing time, enabling high throughput, which is necessary for busy healthcare settings. It minimizes human contact with contaminated instruments, thus lowering the risk of cross-contamination and ensuring consistent adherence to protocols.
Besides, AERs meet high regulatory requirements by offering automated tracking and documentation which further increases compliance and quality assurance. Moreover, advances in technology have allowed them to integrate with hospital systems and make user-friendly features that enhance their reliability and usability.
With the increased focus on infection control and patient safety, AERs are being adopted by more and more healthcare facilities. Though the initial investment is higher, the long-term savings in labor costs and reduced equipment damage make AERs a cost-effective choice.
Increased Efficiency Provided by Automatic Devices Help End Users
Automatic endoscopy processing devices are preferred over semi-automatic devices because they are efficient, safe, and reliable. They fully automate the cleaning and disinfection processes, reducing the time required for reprocessing, which also minimizes the risk of human error.
Moreover, automatic devices provide integrated tracking and documentation features, which help meet regulatory standards. Overall, their ability to streamline workflows and improve safety makes automatic endoscopy processing devices the favored choice in healthcare settings.
Mobile Reprocessing Devices Provide Enhanced Flexibility
Mobile processing devices are more favored than flat-top ones due to the advantage of portability, which facilitates easy shifting from one place to another in healthcare facilities. These provide easy reprocessing throughout the facility with minimal need for dedicated spaces, especially in busy environments, thus optimizing workflow and maximizing space utilization.
Mobile devices also can be readily mobilized to meet variable demands and improve operational efficiency. Overall, the portability and usability of mobile endoscopy processing devices make them a more viable option for healthcare settings.
| Countries | CAGR 2025 to 2035 |
|---|---|
| United States | 4% |
| Japan | 2.6% |
| India | 10.4% |
| Germany | 4% |
| South Korea | 9.5% |
The Japan endoscope reprocessing device market is estimated to advance at a CAGR of 2.6% over the 2025 to 2035 period. In Japan, a high number of patients are preferring minimally invasive surgeries. These surgeries require precise operation of tools and reprocessing devices enable this smooth operation.
Japanese manufacturers are prominent not only locally but worldwide. Japanese companies like Olympus are leaders, providing novel products to the worldwide market. While there is concern over the limited budget available to hospitals in rural areas of Japan, there are still a plethora of opportunities in the country for companies.
The endoscope reprocessing device market in Germany is expected to register a CAGR of 4% from 2025 to 2035. Germany has one of the leading healthcare sectors in Europe. As a result, smart reprocessing systems with AI and machine learning capabilities are becoming popular in the country.
In Germany, rules mandated by various regulatory authorities make reprocessing devices necessary in healthcare settings. The European Union Medical Device Regulation (EU MDR) and Robert Koch Institute (RKI) guidelines are two such standards mandating strict infection protection protocols, necessitating the use of reprocessing devices.
The endoscope reprocessing device market in South Korea is expected to register a CAGR of 9.5% from 2025 to 2035. The South Korean healthcare sector is benefitting from increased government investment in medical facilities. Schemes like the Korea Health Industry Development Institute (KHIDI) increase the adoption of apparatus like endoscopy reprocessing devices.
Another notable factor in South Korea is the rising medical tourism in the country. The proliferation of 5G in the country is enabling healthcare facilities to have advanced equipment, including IoT-enabled endoscopy reprocessing devices. As a result, tourists from all over the world are traveling to South Korea for procedures like endoscopies.
The endoscope reprocessing device market in the United States is set to progress at a CAGR of 4% from 2025 to 2035. The healthcare system in the United States is robust and provides impetus for novel products. As a result, reprocessing devices that enable integration with Electronic Health Records (EHR) as well as IoT-enabled devices are becoming more popular in the country.
Regulatory authorities like the Centers for Disease Control and Prevention (CDC), FDA, and the Association for the Advancement of Medical Instrumentation (AAMI) make it mandatory for endoscopy devices to be kept in proper order. Hence, endoscope reprocessing device sales are shooting up.
Another key factor shaping the landscape in the country is the rising number of the geriatric population. This segment of the population requires endoscopy frequently, leading to more use of reprocessing devices.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The striving for technological progress in the healthcare sector is also reflected in the endoscopy reprocessing device market. With the help of technology, players aim to keep the product line moving and endoscope reprocessing device sales consistent.
One of the notable product launches was Getinge AB launching Enhanced ED-Flow AER in June 2022. It was an updated version of the ED-Flow Automated Endoscope Reprocessor (AER), making significant strides in digital connectivity and data management.
Recognizing the rising importance of endoscopy reprocessing devices, several healthcare companies are entering or expanding their presence in the market. For instance, HOYA Corporation acquired Wassenburg Medical B.V. in November 2023. Wassenburg is a prominent manufacturer of these devices and thus HOYA expanded its footprint in the market through the acquisition.
The market is segmented into automated endoscope reprocessors, washer disinfectors, sterilizers, ultrasonic washers, and drying & storage cabinets based on the product.
Based on the operation mode, the market is bifurcated into semiautomatic and automatic.
In terms of modality, the market is segmented into floor standing/bench top and mobile.
In terms of end users, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, academic & research institutes, and the Central Sterile Services Department (CSSD).
Based on the region, the market is segmented into North America, Latin America, Europe, South Asia, East Asia, Middle East & Africa, and Oceania.
Automated endoscope reprocessor is the most popular product.
The market is predicted to reach a size of USD 4.94 billion by 2035.
The market is anticipated to be valued at USD 2.68 billion in 2025.
The market is predicted to witness a CAGR of 7.3% during the forecast period.
India is set to be a promising country, with a CAGR of 10.4% over the next ten years.
| Estimated Size, 2025 | USD 3,019.8 million |
|---|---|
| Projected Size, 2035 | USD 5,727.5 million |
| CAGR (2025 to 2035) | 6.6% |
| Market Size (2023) | USD 44.2 billion |
|---|---|
| Market Size (2033) | USD 258.87 billion |
| Market Value CAGR (2023 to 2033) | 19.3% |
| Industry Value in 2023 | USD 59.28 billion |
|---|---|
| Industry Value in 2033 | USD 163.84 billion |
| Industry CAGR (2023 to 2033) | 10.7% |
Explore Infection Control Insights
View Reports
Endoscope Reprocessing Device Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
